Chong Kun Dang Q3 Operating Profit Rises 15.4% Year-on-Year

Bitget2026/10/30 06:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Chong Kun Dang Pharmaceutical’s third-quarter 2026 operating profit rose 15.4% year over year to KRW 23.67 billion.
Revenue increased 0.8% from a year earlier to KRW 430.73 billion.
Net profit fell 6.5% year over year to KRW 18.77 billion.
Revenue for January–September 2026 reached KRW 1.35 trillion, up 7.8% year over year.
Operating profit for the nine months increased 10.2% to KRW 61.16 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chong Kun Dang Pharmaceutical Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030800726), on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Chong Kun Dang Q3 Operating Profit Rises 15.4% Year-on-Year

You may also like

Crypto prices